about
Using PM2.5 concentrations to estimate the health burden from solid fuel combustion, with application to Irish and Scottish homesContribution of solid fuel, gas combustion, or tobacco smoke to indoor air pollutant concentrations in Irish and Scottish homesValidation of the inhalable dust algorithm of the Advanced REACH Tool using a dataset from the pharmaceutical industry.Workplace exposure to bioaerosols in podiatry clinics.Health and Safety in Podiatric Medicine Findings from a National Survey of Irish Podiatric Physicians.Exposure assessment using human biomonitoring for glyphosate and fluroxypyr users in amenity horticulture.Refinement and validation of an exposure model for the pharmaceutical industry.An evaluation of on-tool shrouds for controlling respirable crystalline silica in restoration stone work.Exploring the half-life of glyphosate in human urine samplesDeterminants of Respirable Crystalline Silica Exposure Among Stoneworkers Involved in Stone Restoration WorkExposure to Inhalable Dust, Endotoxin, and Total Volatile Organic Carbons on Dairy Farms Using Manual and Automated Feeding SystemsFungal burden exposure assessment in podiatry clinics from IrelandGlyphosate in Irish adults – A pilot study in 2017Evaluating worker vibration exposures using self-reported and direct observation estimates of exposure durationEvaluation of hand-arm and whole-body vibrations in construction and property managementCharacterising glyphosate exposures among amenity horticulturists using multiple spot urine samplesPerfluoroalkyl Substances in Drinking Water, Indoor Air and Dust from Ireland: Implications for Human ExposureConcentrations of Brominated Flame Retardants in Indoor Air and Dust from Ireland Reveal Elevated Exposure to Decabromodiphenyl EthaneOccupational Exposures in an Equestrian Centre to Respirable Dust and Respirable Crystalline Silica
P50
Q28680659-65F88C3C-25C7-4143-B927-0F5F29509E24Q28708929-29E30B14-6C24-4E57-AA2C-8333A1264E2DQ43630397-8B57C871-5218-48DB-9F0B-E59B2FB7F231Q45561845-9CD8E3E6-A861-4C09-9E7D-E5C5A1DB2D18Q49680814-74923A11-41D1-47C6-9AE5-9CA73563CED0Q50550664-98DF061F-AFA6-48A9-929E-ADC71BA3C0ABQ51610045-5F7EA70B-DB33-412C-84E9-F262B280F13CQ51694963-FD42BE99-5011-496A-96AC-32004FB429D9Q57186863-AC55469C-F339-4ED4-97B6-A2E4D65864D1Q57429104-81841A8A-3D3A-47C5-A1F4-25B1EC33393AQ57618524-04E47890-485A-4D5E-BE45-25CA336F3222Q58042497-4B4B727A-18EB-4534-8CDB-0F3F9D234CA5Q59265668-26A26F23-194F-47EF-A50A-A17E00BA884BQ84208475-0A8C90F7-B023-48FC-8294-E464D3884F47Q85103927-9F981CFD-5A34-4BF2-9DF9-2F69FC0598D1Q90759853-F7250AA7-DD33-4DCF-8A0C-0DBC3CBCBE02Q91188757-FCDCC83F-F061-4AC0-BDFF-5A940B394DD7Q91918936-3EEB0272-6CF9-470C-8924-F6B923C6F023Q93103272-3C32CDEB-F30C-4D11-906A-C17DE9BB418C
P50
description
investigador
@es
researcher
@en
name
M Coggins
@en
type
label
M Coggins
@en
prefLabel
M Coggins
@en
P31
P496
0000-0002-7318-8994